Epidemiology, molecular, and genetic methodologies to evaluate causes of CKDu around the world: report of the Working Group from the ISN International Consortium of Collaborators on CKDu (2019) Anand S, Caplin B, Gonzalez-Quiroz M, Schensul SL, Bhalla V, Parada X, Nanayakkara N, et al. Journal article, Editorial Hypercalcemia mimicking myocardial infarction (2019) Schmidt-Lauber C, Anneken L, Schödel J Journal article Tuberculous granulomatous interstitial nephritis in a renal allograft (2019) Schmidt-Lauber C, Büttner-Herold M, Schiffer M, Wiesener M Journal article Considerable international variation exists in blood pressure control and antihypertensive prescription patterns in chronic kidney disease (2019) Alencar de Pinho N, Levin A, Fukagawa M, Hoy WE, Pecoits-Filho R, Reichel H, Robinson B, et al. Journal article Chronic kidney disease and valvular heart disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference (2019) Marwick TH, Amann KU, Bangalore S, Cavalcante JL, Charytan DM, Craig JC, Gill JS, et al. Journal article Corticosteroid treatment exacerbates nephrotic syndrome in a zebrafish model of magi2a knockout (2019) Jobst-Schwan T, Hoogstraten CA, Kolvenbach CM, Schmidt JM, Kolb A, Eddy K, Schneider R, et al. Journal article Blood pressure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference (2019) Cheung AK, Chang TI, Cushman WC, Furth SL, Ix JH, Pecoits-Filho R, Perkovic V, et al. Journal article Sodium and water handling during hemodialysis: new pathophysiologic insights and management approaches for improving outcomes in end-stage kidney disease (2019) Canaud B, Kooman J, Selby NM, Taal M, Francis S, Kopperschmidt P, Maierhofer A, et al. Journal article, Review article Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. (2019) House AA, Wanner C, Sarnak MJ, Pina IL, Mcintyre CW, Komenda P, Kasiske BL, et al. Journal article An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients. (2019) Sommerer C, Suwelack B, Dragun D, Schenker P, Hauser IA, Witzke O, Hugo C, et al. Journal article